BioImagene, the innovative provider of digital pathology solutions, announced today the close of its $4.2 million Series B financing led by Tuputele Ventures, Authosis, Inc. and ICCP Ventures. BioImagene will use these funds to launch its product globally and to expand its sales and marketing efforts in North America, Europe and Asia Pacific.
